Szurkowska M
Jagiellonian University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Szurkowska M.
Acta Cardiologica | 2005
Ewa Stochmal; Szurkowska M; Danuta Czarnecka; Anna Stochmal; Artur Klecha; Kalina Kawecka-Jaszcz; Szybiński Z
Objectives — The purpose of the study was to evaluate the role of insulin resistance (IR) in the development of coronary atherosclerosis in patients with impaired glucose tolerance. Methods and results — The study group consisted of 42 patients with impaired glucose tolerance. Based upon coronary angiography the patients were divided into group A – with prior myocardial infarction and critical coronary stenosis (n = 20) and group B – without prior myocardial infarction and without critical coronary stenosis (n = 22). In each patient glucose disposal rate (GDR) during metabolic clamp, insulinaemia in the fasting state and during the clamp, glycaemia during oral glucose tolerance test (OGTT), BMI and body mass composition were measured.The groups did not differ in age, BMI, percent fat content and distribution, and blood pressure. Fasting insulinaemia (56.7 mU/ml) was higher in group A than in group B (22.3 μU/ml). GDR in group A (2.96 mg/kg b.m./min) was lower than in group B (5.36 mg/kg b.m./min).There was a negative correlation between the number of critically narrowed coronary vessels and GDR in group A. GDR below 3.97 mg/kg b.m./min was found, based on regression analysis, to be a powerful risk factor for myocardial infarction. Conclusions — The relationship between IR and severity of coronary atherosclerosis implies its unfavourable role in the development of atherosclerosis. The present findings indicate a negative role of IR in the development of myocardial infarction and suggest that it is an independent risk factor, which identifies high-risk patients requiring treatment that would increase tissue insulin sensitivity.
Metabolism-clinical and Experimental | 2007
Andrzej Surdacki; Ewa Stochmal; Szurkowska M; Stefanie M. Bode-Böger; Jens Martens-Lobenhoffer; Anna Stochmal; Artur Klecha; Kalina Kawecka-Jaszcz; Jacek S. Dubiel; Huszno B; Szybiński Z
Przegla̧d lekarski | 2006
Szurkowska M; Krystyna Szafraniec; Aleksandra Gilis-Januszewska; Dorota Pach; Krzentowska A; Szybiński Z; Huszno B
Przegla̧d epidemiologiczny | 2005
Szurkowska M; Krystyna Szafraniec; Aleksandra Gilis-Januszewska; Szybiński Z; Huszno B
Nuclear Medicine Review | 2008
Alicja Hubalewska-Dydejczyk; Wojciech Jurczak; Anna Sowa-Staszczak; Jolanta Kunikowska; Leszek Królicki; Aleksandra Gilis-Januszewska; Agnieszka Giza; Szurkowska M; Dorota Pach; Bogusław Głowa; Renata Mikolajczak; Dariusz Pawlak; Agnieszka Stefanska; Huszno B; Aleksander B. Skotnicki
Przegla̧d lekarski | 2007
Dorota Pach; Alicja Hubalewska-Dydejczyk; Szurkowska M; Kamenczak A; Targosz D; Gawlikowski T; Huszno B; Głowa B
Przegla̧d lekarski | 2007
Szurkowska M; Krystyna Szafraniec; Dorota Pach; Targosz D; Beata Piwonska-Solska; Alicja Hubalewska-Dydejczyk; Szybiński Z; Huszno B
Przegla̧d lekarski | 2006
Szurkowska M; Krystyna Szafraniec; Aleksandra Gilis-Januszewska; Dorota Pach; Krzentowska A; Szybiński Z; Huszno B
Przegla̧d lekarski | 2007
Dorota Pach; Szurkowska M; Targosz D; Kamenczak A; Mikołaszek-Boba M; Krystyna Szafraniec; Winnik L; Hydzik P; Huszno B
Epidemiology | 2005
Szurkowska M; Aleksandra Gilis-Januszewska; Dorota Pach; Krystyna Szafraniec; Z Szybi ski